Molecular Diagnostics


New Way to Identify Influenza A Virus Could Pave Way for More Sensitive Tests
Because the influenza A virus is constantly changing, or mutating, it can be difficult to detect, treat, and inoculate against. By finding new ways to target specific parts of the influenza A virus that do not change when the virus mutates, more sensitive tests can be created to detect the influenza A virus more easily. More...08 Jun 2022


Blood Test Combines Epigenetics, NGS and Machine Learning for Multi-Cancer Early Detection
A qualitative next-generation sequencing (NGS)-based in vitro diagnostic device that detects DNA methylation markers using cfDNA isolated from human peripheral whole blood enables earlier detection and localization of multiple cancer types. More...07 Jun 2022

Quantitative Diagnostic System Delivers Results in Minutes at True POC Situation
A unique quantitative diagnostic system could offer a highly effective and affordable alternative to the current costly and time-consuming screening and monitoring systems currently available in the market. More...07 Jun 2022

Biodesix’s MRD Test for Solid Tumors to Run on Bio-Rad's Upcoming QX600 ddPCR System
Biodesix, Inc. (Boulder, CO, USA) is developing a new novel minimal residual disease (MRD) test in association with the Memorial Sloan Kettering Cancer Center (MSK, New York, NY, USA) that will utilize the advanced multiplexing QX600 ddPCR System to be launched by Bio-Rad Laboratories (Hercules, CA, USA) later this year. More...07 Jun 2022

Blood Test Enables Early Detection of Oral Cancer
Researchers have used a technology called conductive polymer spray ionization mass spectrometry to screen the blood for metabolic signs of oral squamous cell carcinoma (OSCC) - a type of cancer of the mouth and throat - that contributes around 90% of oral cancers. More...07 Jun 2022
In Other News
- MIS-C Linked to Rare, Immune-Related Variants
- Noninvasive Blood Test Predicts Rejection After Heart Transplant
- Genome-Wide NIPT Uncovers Additional Findings
- Proteomics-based Blood Test May Replace Biopsy for Diagnosis of Liver Disease
- Novel Method Uses DNA Droplets for Early Disease Detection
- Testing for DNA Shed from Colon Cancers into Bloodstream Guides Chemotherapy After Surgery
- Blood Test May Be a Game-Changer for TB Diagnoses and Treatment
- Blood Test Detects and Monitors Cell Death to Predict Disease Severity
- Non-Invasive Tests for Diagnosing Liver Diseases Could Shape Future Clinical Care
- Results of Alzheimer’s Disease Blood Tests Are Skewed by Unrelated Chronic Conditions
- Liquid Biopsy Predicts Success of ICI Treatment in Lung Cancer Patients
- Lung Cancer Detection Blood Test to Reduce Need for Repeated CT Scanning
- Molecular Profiling Identifies High-Risk Subtype of Pediatric Liver Cancer
- Roche Develops Monkeypox Virus Detection PCR Tests
- POC Critical Illness Test Designed for Early Warning and Patient Triaging
- World’s First Biomarker Can Diagnose Parkinson's Disease from Blood Serum Samples
- Tear Fluid Collected Using Noninvasive Technique Could Help Diagnose Diseases
- Illumina’s Pan-Cancer Companion Diagnostic Enables Targeted Therapy
- LumiraDx HbA1c Assay Screens and Identifies Patients at Risk for Developing Diabetes
- POC System Could Transform Infectious Disease Management
- mRNA Test Screens for Multiple Cancers from Single Blood Sample
- A Circulating Antibody Enables Prediction of Crohn’s Disease Long Before Symptoms Appear
- Bioperfectus Monkeypox Virus Real Time PCR Kit Receives CE Mark
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.













 
								

 
								
 
								
